Treatments based on genomic profiling can significantly extend survival for patients with advanced or rare cancer, but only ...

It's a fundamental principle of science: Correlation does not equal causation. Every cancer cell has genetic mutations, but ...

Vepdegestrant becomes the first FDA-approved heterobifunctional protein degrader (PROTAC) in breast cancer, targeting ER ...

New breast cancer pill eliminates tumor proteins and improves treatment response in patients by making the estrogen receptor ...

A first-in-human clinical trial led by an international team of researchers and published in the New England Journal of ...

Scientists have uncovered a surprising overlap between cancer genetics and Alzheimer’s disease, involving mutations in the ...

An experimental drug from Revolution Medicines that nearly ​doubled survival time for patients with advanced pancreas cancer ...

Sperm from a single donor in Europe has reportedly been used to conceive at least 67 pregnancies, although the donor carried a rare cancer-causing mutation. The donor’s mutation has been linked to ...

About half of people diagnosed with metastatic non-small-cell lung cancer never receive treatment, despite advances in ...